This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Slusher, J T Articles by Lietman, P S Search for Related Content PubMed PubMed Citation Articles by Slusher, J T Articles by Lietman, P S

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1992 November; 36(11): 2473-2477

Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.

J T Slusher, S K Kuwahara, F M Hamzeh, L D Lewis, D M Kornhauser and P S Lietman

Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-5554.

ABSTRACT

In vitro studies of zidovudine (ZDV) phosphorylation may not accurately reflect the in vivo dose-response relationship, which is crucial to determining the relationship between ZDV exposure, efficacy, and toxicity. However, measurement of ZDV phosphorylated anabolites in peripheral blood mononuclear cells (PBMCs) from ZDV-treated human immunodeficiency virus (HIV)-infected patients would be extremely useful in the more appropriate utilization of ZDV in the treatment of HIV infection. We developed a specific and sensitive combined high-pressure liquid chromatography (HPLC)-radioimmunoassay (RIA) procedure for the determination of ZDV, ZDV-monophosphate, ZDV-diphosphate, and ZDV-triphosphate in PBMCs taken from ZDV-treated HIV-infected patients. ZDV and its anabolites were extracted from washed, Ficoll-Paque-isolated PBMCs and then separated by HPLC using a strong anion-exchange column. The anabolites were then hydrolyzed to ZDV with acid phosphatase. ZDV was then measured by using a modified commercially available RIA protocol. Our method was validated by measuring [3H]ZDV anabolites generated in Molt-4 cells radioisotopically and simultaneously by the combined HPLC-RIA procedure. The ZDV determinations correlated well (r2 = 0.97) over the range of 0.037 to 5.2 pmol (10 to 1,400 pg) per assay tube. Furthermore, we defined the stability of ZDV anabolites during ficoll isolation and the recovery after extraction and cleanup. We then measured intracellular parent ZDV and its phosphorylated anabolites in PBMCs from six ZDV-treated HIV-infected patients (PBMCs were taken 2 h after a 300-mg oral dose). The mean concentrations ( +/- standard deviations) of parent and of mono-, di-, and triphosphates were 0.15 +/- 0.08, 1.4 +/-, 0.082 +/- 0.02, and 0.081 +/- 0.03 pmol/10(6) PBMC, respectively (one pmol/10(6) PBMC represents a concentration of approximately 1 microm). Concurrent serum ZDV concentrations were between 1.3 and 7.1 microm. This method should provide a useful tool for evaluating in vivo pharmacokinetics of ZDV anabolites in PBMCs and possibly other cell types, even at the low doses of ZDV currently administered therapeutically.

---

Antimicrob Agents Chemother. 1992 November; 36(11): 2473-2477

This article has been cited by other articles:

• Kewn, S., Hoggard, P. G., Sales, S. D., Jones, K., Maher, B., Khoo, S. H., Back, D. J. (2002). Development of Enzymatic Assays for Quantification of Intracellular Lamivudine and Carbovir Triphosphate Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother. 46: 135-143 [Abstract] [Full Text]  
• Moore, S. M., Cannon, J. S., Tanhehco, Y. C., Hamzeh, F. M., Ambinder, R. F. (2001). Induction of Epstein-Barr Virus Kinases To Sensitize Tumor Cells to Nucleoside Analogues. Antimicrob. Agents Chemother. 45: 2082-2091 [Abstract] [Full Text]  
• Rodriguez, J. F., Rodriguez, J. L., Santana, J., García, H., Rosario, O. (2000). Simultaneous Quantitation of Intracellular Zidovudine and Lamivudine Triphosphates in Human Immunodeficiency Virus-Infected Individuals. Antimicrob. Agents Chemother. 44: 3097-3100 [Abstract] [Full Text]  
• Font, E., Rosario, O., Santana, J., García, H., Sommadossi, J.-P., Rodriguez, J. F. (1999). Determination of Zidovudine Triphosphate Intracellular Concentrations in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Individuals by Tandem Mass Spectrometry. Antimicrob. Agents Chemother. 43: 2964-2968 [Abstract] [Full Text]  
• Darque, A., Valette, G., Rousseau, F., Wang, L. H., Sommadossi, J.-P., Zhou, X.-J. (1999). Quantitation of Intracellular Triphosphate of Emtricitabine in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother. 43: 2245-2250 [Abstract] [Full Text]  
• Kashuba, A. D. M., Dyer, J. R., Kramer, L. M., Raasch, R. H., Eron, J. J., Cohen, M. S. (1999). Antiretroviral-Drug Concentrations in Semen: Implications for Sexual Transmission of Human Immunodeficiency Virus Type 1. Antimicrob. Agents Chemother. 43: 1817-1826 [Full Text]  
• Cannon, J. S., Hamzeh, F., Moore, S., Nicholas, J., Ambinder, R. F. (1999). Human Herpesvirus 8-Encoded Thymidine Kinase and Phosphotransferase Homologues Confer Sensitivity to Ganciclovir. J. Virol. 73: 4786-4793 [Abstract] [Full Text]  
• Solas, C., Li, Y.-F., Xie, M.-Y., Sommadossi, J.-P., Zhou, X.-J. (1998). Intracellular Nucleotides of (-)-2',3'-Deoxy-3'-Thiacytidine in Peripheral Blood Mononuclear Cells of a Patient Infected with Human Immunodeficiency Virus. Antimicrob. Agents Chemother. 42: 2989-2995 [Abstract] [Full Text]  
• Mei, J. V., Hannon, W. H., Dobbs, T. L., Bell, C. J., Spruill, C., Gwinn, M. (1998). Radioimmunoassay for monitoring zidovudine in dried blood spot specimens. Clin. Chem. 44: 281-286 [Abstract] [Full Text]  
• Chow, H.-H., Li, P., Brookshier, G., Tang, Y. (1997). In Vivo Tissue Disposition of 3'-Azido-3'-deoxythymidine and Its Anabolites in Control and Retrovirus-Infected Mice. Drug Metab. Dispos. 25: 412-422 [Abstract] [Full Text]